Should Juries Try To Predict FDA Drug Labeling Decisions?
On June 28, 2018, the Supreme Court of the United States accepted for review Merck Sharp & Dohme Corp. v. Albrecht, an appeal from the Third Circuit Court of Appeals' decision...To view the full article, register now.
Already a subscriber? Click here to view full article